NCT06239272 2026-01-26NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)St. Jude Children's Research HospitalPhase 1/2 Recruiting139 enrolled
NCT03277924 2024-08-13ImmunoSarcGrupo Espanol de Investigacion en SarcomasPhase 1/2 Completed197 enrolled
NCT02584309 2023-11-07Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue SarcomaWashington University School of MedicinePhase 2 Completed73 enrolled 11 charts
NCT03009201 2023-08-16Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by SurgeryOHSU Knight Cancer InstitutePhase 1 Completed16 enrolled